연구업적

연구

연구
연구업적

최근 5년 연구업적 현황

연도		2023년	2022년	2021년	2020년	2019년
SCI 논문 발표편수	책임	173편	163편	184편	135편	144편
SCI 논문 발표편수	공동	120편	115편	136편	168편	167편
합계		293편	278편	320편	303편	311편

841. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.

Park J, Ahn KS, Bae EK, Kim BS, Kim BK, Lee YY, Yoon SS.

Anticancer Drugs. 2008 Sep;19(8):777-82 Link

840. Clinical predictors of recurrent venous thromboembolism: A single institute experience in Korea.

Kim TM, Kim JS, Han SW, Hong YS, Kim I, Ha J, Kim SJ, Chung JW, Park JH, Lee D, Park S, Kim BK, Kim NK, Yoon SS.

Thromb Res. 2008 Jun 23. Link

839. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.

Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI

Laryngoscope. 2008 Apr;118(4):663-70 Link

838. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.

Jang WI, Wu HG, Park CI, Kim KH, Sung MW, Kim MJ, Choung PH, Lee JH, Choi JY.

Jpn J Clin Oncol. 2008 Jun;38(6):395-401 Link

837. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.

Chang AR, Wu HG, Park CI, Jun YK, Kim CW.

Head Neck. 2008 Jul;30(7):852-7 Link

836. Clinicopathological features and surgical outcomes of patients with remnant gastric cancer after a distal gastrectomy.

Ahn HS, Kim JW, Yoo MW, Park do J, Lee HJ, Lee KU, Yang HK.

Ann Surg Oncol. 2008 Jun;15(6):1632-9. Link

835. Synchronous and metachronous cancers in patients with gastric cancer.

Eom BW, Lee HJ, Yoo MW, Cho JJ, Kim WH, Yang HK, Lee KU.

J Surg Oncol. 2008 Aug 1;98(2):106-10 Link

834. Clinical outcome of pylorus-preserving gastrectomy in gastric cancer in comparison with conventional distal gastrectomy with Billroth I anastomosis.

Park do J, Lee HJ, Jung HC, Kim WH, Lee KU, Yang HK.

World J Surg. 2008 Jun;32(6):1029-36 Link

833. Acute intestinal pseudo-obstruction after induction treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.

Park JA, Yun JH, Kang HJ, Shin HY, Ahn HS.

Pediatr Blood Cancer. 2008 Apr;50(4):872-4. Link

832. Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer.

Lee HP, Seo SS, Ryu SY, Kim JH, Bang YJ, Park SY, Nam JH, Kang SB, Lee KH, Song YS.

Gynecol Oncol. 2008 Jun;109(3):359-63 Link